(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors.
Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M, Altamura C, Galecki P, Berk M.
Maes M, et al. Among authors: berk m.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):659-63. doi: 10.1016/j.pnpbp.2011.02.019. Epub 2011 Mar 2.
Prog Neuropsychopharmacol Biol Psychiatry. 2011.
PMID: 21376099
No abstract available.